235 related articles for article (PubMed ID: 31145136)
1. Supplemental oxygen for the management of dyspnea in interstitial lung disease.
Schaeffer MR; Molgat-Seon Y; Ryerson CJ; Guenette JA
Curr Opin Support Palliat Care; 2019 Sep; 13(3):174-178. PubMed ID: 31145136
[TBL] [Abstract][Full Text] [Related]
2. The impact of carrying supplemental oxygen on exercise capacity and dyspnea in patients with interstitial lung disease.
Ramadurai D; Riordan M; Graney B; Churney T; Olson AL; Swigris JJ
Respir Med; 2018 May; 138():32-37. PubMed ID: 29724390
[TBL] [Abstract][Full Text] [Related]
3. Oxygen for interstitial lung diseases.
Khor YH; Smith DJF; Johannson KA; Renzoni E
Curr Opin Pulm Med; 2020 Sep; 26(5):464-469. PubMed ID: 32657832
[TBL] [Abstract][Full Text] [Related]
4. Palliative oxygen for chronic breathlessness: what new evidence?
Ahmadi Z; Currow DC; Ekström M
Curr Opin Support Palliat Care; 2017 Sep; 11(3):159-164. PubMed ID: 28644301
[TBL] [Abstract][Full Text] [Related]
5. A randomized cross-over trial on the direct effects of oxygen supplementation therapy using different devices on cycle endurance in hypoxemic patients with Interstitial Lung Disease.
Edvardsen A; Jarosch I; Grongstad A; Wiegand L; Gloeckl R; Kenn K; Spruit MA
PLoS One; 2018; 13(12):e0209069. PubMed ID: 30592724
[TBL] [Abstract][Full Text] [Related]
6. Ambulatory and short-burst oxygen for interstitial lung disease.
Sharp C; Adamali H; Millar AB
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD011716. PubMed ID: 27383922
[TBL] [Abstract][Full Text] [Related]
7. Acute effect of oxygen therapy on exercise tolerance and dyspnea perception in ILD patients.
Ora J; Coppola A; Perduno A; Manzetti GM; Puxeddu E; Rogliani P
Monaldi Arch Chest Dis; 2021 Oct; 92(2):. PubMed ID: 34634897
[TBL] [Abstract][Full Text] [Related]
8. Interstitial lung disease and pulmonary rehabilitation.
Garvey C
J Cardiopulm Rehabil Prev; 2010; 30(3):141-6. PubMed ID: 20040881
[TBL] [Abstract][Full Text] [Related]
9. Qualitative dimensions of exertional dyspnea in fibrotic interstitial lung disease.
Schaeffer MR; Guenette JA; Ramsook AH; Molgat-Seon Y; Mitchell RA; Wilkie SS; Dhillon SS; Sheel AW; Ryerson CJ
Respir Physiol Neurobiol; 2019 Aug; 266():1-8. PubMed ID: 30986534
[TBL] [Abstract][Full Text] [Related]
10. Supplemental Oxygen Therapy in Interstitial Lung Disease: A Narrative Review.
Clark KP; Degenholtz HB; Lindell KO; Kass DJ
Ann Am Thorac Soc; 2023 Nov; 20(11):1541-1549. PubMed ID: 37590496
[TBL] [Abstract][Full Text] [Related]
11. Supplemental Oxygen in Interstitial Lung Disease: An Art in Need of Science.
Johannson KA; Pendharkar SR; Mathison K; Fell CD; Guenette JA; Kalluri M; Kolb M; Ryerson CJ
Ann Am Thorac Soc; 2017 Sep; 14(9):1373-1377. PubMed ID: 28644693
[TBL] [Abstract][Full Text] [Related]
12. Inspiratory neural drive and dyspnea in interstitial lung disease: Effect of inhaled fentanyl.
Milne KM; Ibrahim-Masthan M; Scheeren RE; James MD; Phillips DB; Moran-Mendoza O; Ja N; O'Donnell DE
Respir Physiol Neurobiol; 2020 Nov; 282():103511. PubMed ID: 32758677
[TBL] [Abstract][Full Text] [Related]
13. Management of Chronic Respiratory Failure in Interstitial Lung Diseases: Overview and Clinical Insights.
Faverio P; De Giacomi F; Bonaiti G; Stainer A; Sardella L; Pellegrino G; Sferrazza Papa GF; Bini F; Bodini BD; Carone M; Annoni S; Messinesi G; Pesci A
Int J Med Sci; 2019; 16(7):967-980. PubMed ID: 31341410
[TBL] [Abstract][Full Text] [Related]
14. Ambulatory oxygen in fibrotic lung disease (AmbOx): study protocol for a randomised controlled trial.
Visca D; Tsipouri V; Mori L; Firouzi A; Fleming S; Farquhar M; Leung E; Maher TM; Cullinan P; Hopkinson N; Wells AU; Banya W; Whitty JA; Adamali H; Spencer LG; Sestini P; Renzoni EA
Trials; 2017 Apr; 18(1):201. PubMed ID: 28454553
[TBL] [Abstract][Full Text] [Related]
15. Management of dyspnea in interstitial lung disease.
Ryerson CJ; Collard HR; Pantilat SZ
Curr Opin Support Palliat Care; 2010 Jun; 4(2):69-75. PubMed ID: 20375900
[TBL] [Abstract][Full Text] [Related]
16. The effect of domiciliary high flow nasal cannula treatment on dyspnea and walking distance in patients with interstitial lung disease - A pilot study.
Weinreich UM; Burchardt C; Huremovic J
Chron Respir Dis; 2022; 19():14799731221137085. PubMed ID: 36366859
[TBL] [Abstract][Full Text] [Related]
17. The effect of heated humidified nasal high flow oxygen supply on exercise tolerance in patients with interstitial lung disease: A pilot study.
Al Chikhanie Y; Veale D; Verges S; Hérengt F
Respir Med; 2021 Sep; 186():106523. PubMed ID: 34225230
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiological mechanisms of exertional breathlessness in chronic obstructive pulmonary disease and interstitial lung disease.
Jensen D; Schaeffer MR; Guenette JA
Curr Opin Support Palliat Care; 2018 Sep; 12(3):237-245. PubMed ID: 30074922
[TBL] [Abstract][Full Text] [Related]
19. Exercise Pathophysiology in Interstitial Lung Disease.
Molgat-Seon Y; Schaeffer MR; Ryerson CJ; Guenette JA
Clin Chest Med; 2019 Jun; 40(2):405-420. PubMed ID: 31078218
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of supplemental oxygen for dyspnea relief in patients with advanced progressive illness: A systematic review and meta-analysis.
Hasegawa T; Ochi T; Goya S; Matsuda Y; Kako J; Watanabe H; Kasahara Y; Kohara H; Mori M; Nakayama T; Yamaguchi T
Respir Investig; 2023 Jul; 61(4):418-437. PubMed ID: 37105126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
